Action MUSCLE PHARM CORPORATION.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Muscle Pharm Corporation. OTC Bulletin Board

Actions

US6273351022

Cours en clôture OTC Bulletin Board
Autres places de cotation
- USD - Graphique intraday de Muscle Pharm Corporation.
2023 MusclePharm Corporation obtient une seconde prolongation de sa période d'exclusivité CI
2023 FitLife Brands, Inc. (NasdaqCM:FTLF) a conclu l'acquisition de la quasi-totalité des actifs de MusclePharm Corporation (OTCPK:MSLP.Q). CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).
Motion for Asset Sale Approved for MusclePharm Corporation
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.
Stalking Horse Agreement Filed by MusclePharm Corporation
Musclepharm Corporation Announces Resignation of Paul Karr as Director
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation
First Amended Disclosure Statement Approved for MusclePharm Corporation
Bidding Procedure Approved for MusclePharm Corporation
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer
SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation
Motion for Asset Sale Filed by MusclePharm Corporation
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.
First Motion for Exclusivity Period Extension Filed by MusclePharm Corporation
DIP Financing Approved for MusclePharm Corporation
Amended DIP Financing Approved for MusclePharm Corporation
Interim DIP Financing Approved for MusclePharm Corporation
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action MSLP
  4. Action
  5. Actualités Muscle Pharm Corporation.
  6. Autres langues